NRG Energy's shares skyrocketed 25%, marking a transformative moment for the company with impressive earnings boosting its appeal. Apple also saw gains after President Trump had a chat with CEO Tim Cook, amid speculation of iPhone price hikes that could introduce exciting new features. In contrast, CVS and other healthcare stocks dipped after Trump proposed eliminating drug middlemen to cut costs. Market dynamics reflect a mixed bag of opportunities and challenges, leaving investors eager to gauge the next big move.
05:26
forum Ask episode
web_stories AI Snips
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
insights INSIGHT
NRG's Transformative Power Deal
NRG Energy shares surged 26% after its $12 billion deal to acquire net gas-powered assets.
The deal is seen as transformative, doubling the company's power generation capacity and improving earnings.
insights INSIGHT
Apple Considers iPhone Price Hikes
Apple's stock rose 6% after reports it might raise iPhone prices with new features this fall.
The company aims to avoid linking price hikes to US tariffs to maintain consumer perception.
insights INSIGHT
Trump Targets Drug Industry Middlemen
Shares of health-care companies owning pharmacy-benefit managers (PBMs) fell after Trump's proposal to cut out middlemen to lower drug prices.
Trump signed an executive order asking drugmakers to reduce prices voluntarily or face regulation, causing initial fear but weaker-than-expected action.
Get the Snipd Podcast app to discover more snips from this episode
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Alix Steel, Scarlet Fu, Carol Massar and Matt Miller.
- NRG Energy (NRG) shares soared 25%, the most intraday since 2017 to a record high, as Wall Street praised its deal that Jefferies says is “transforming” the company and doubling its power generation capacity, while the power producer also reported better-than-expected adjusted Ebitda for the first quarter.
- Apple (AAPL) shares rose after US President Donald Trump said he spoke with CEO Tim Cook earlier on Monday, just as the iPhone maker was reported to be considering price increases later this year. Apple is weighing whether to raise prices for an iPhone lineup coming in the fall, the Wall Street Journal reported, citing people familiar with the matter whom it didn’t identify. The company is exploring whether to “couple” price increases with new features and designs, while trying to avoid the perception that any hikes are tied to US tariffs, the Journal reported. Apple didn’t respond to Bloomberg’s request for comment.
- CVS (CVS) shares, along with other major US health-care companies that own pharmacy-benefit management units closed lower after President Donald Trump proposed a plan to “cut out” the drug-industry middlemen as a way to reduce drug costs. Trump aims to do so by bringing drugmakers to the negotiating table. He signed an executive order today asking them to lower prices voluntarily or else face regulatory measures. Pharmaceutical companies had expected — and feared — action on drug prices. However, the order was far weaker than they’d anticipated. Shares of major drugmakers initially fell after Trump teased drug-price action on social media Sunday night, then rose as details on the order emerged throughout Monday morning.
Stock Movers